From microbiome to metabolism: Bridging a two-decade translational gap

Area of Science:

• Microbiome research
• Human health and disease
• Systems biology

Background:

• The human genome project initially promised medical advances, but focus has shifted to the human microbiome's role in health and disease.
• Numerous associations exist between gut microbiota and conditions like obesity, diabetes, inflammatory bowel disease, autism, and cancer.
• Current research faces challenges due to a lack of causal evidence in many "dysbiosis" studies and difficulties translating animal model findings to humans.

Purpose of the Study:

• To discuss the transformative potential of microbiome research in understanding and treating diseases.
• To advocate for a shift from reductionist approaches to systems biology and personalized interventions.
• To highlight the need for precision, functional profiling, and multi-omics integration, potentially using artificial intelligence.

Main Methods:

• Review of existing literature on human microbiome research and its association with diseases.
• Discussion of the limitations of current correlative studies and animal models.
• Exploration of advanced approaches like multi-omics integration and artificial intelligence for deeper insights.

Main Results:

• Pioneering studies show significant inter-individual variation in the gut microbiota.
• Correlative studies have linked gut microbiota to a wide array of diseases, but causal evidence is often limited.
• Clinical interventions like fecal microbiota transplantation, prebiotics, and probiotics show inconsistent or modest results.

Conclusions:

• There is a critical need to move beyond correlative studies and establish causal links in microbiome research.
• Precision, functional profiling, and multi-omics data integration are essential for advancing the field.
• Adopting a systems biology approach and personalized interventions offers a more promising path for leveraging microbiome research for health and disease management.